Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,829.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $11,829.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on October 27, 2025, with an ultimate completion date of October 28, 2025, represents a single award with no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group specializes in distributing a comprehensive portfolio of pharmaceutical products and medical consumables to Department of Defense healthcare facilities, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications.
This delivery order was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9 billion acquisition strategy designed to support recurring medical supply needs of military healthcare facilities worldwide. The underlying PPV-G GEN V contract, awarded on November 13, 2025, positions DMS Pharmaceutical Group as a critical regional prime vendor contractor authorized to fulfill the diverse pharmaceutical requirements of the federal military medical system. The company has demonstrated substantial federal contracting activity through multiple delivery orders issued by DLA's Medical Supply Chain division, with no identified subcontractor relationships, establishing its role as a direct supplier of essential pharmaceutical products to Department of Defense operations.
Quick answers
Who was awarded contract SPE2DU26FEMMD?
SPE2DU26FEMMD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 27, 2025.
How much is contract SPE2DU26FEMMD worth?
The government has obligated $11,830 on SPE2DU26FEMMD.
Is contract SPE2DU26FEMMD an order under another contract?
Yes. SPE2DU26FEMMD is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMD competed?
The extent of competition for SPE2DU26FEMMD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award